Loading…
Biotech Next Gen 2021 has ended
Back To Schedule
Tuesday, June 22 • 11:00am - 11:25am
Enabling base editing research via automation and a cloud connected lab

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
Base editing — a new class of precision genetic medicines — has the potential of providing life-long cures to patients suffering from serious diseases. Yet base editing research is complex and demanding, requiring the processing of large sample amounts and tracking of complex data. In this presentation, learn how Beam Therapeutics pioneers this novel therapeutic by leveraging automation and Benchling's unified, cloud-based R&D informatics platform.

Speakers
avatar for Lauren Shields

Lauren Shields

Head of Technical Solutions Consulting, Benchling
Lauren Shields is the Head of Technical Solutions Consulting at Benchling. After receiving her BS in Biology at MIT, she was awarded a Fulbright Scholarship to conduct research at the Université de Lausanne in Switzerland. Lauren went on to attain her PhD at UCSF, working in the... Read More →
avatar for Bob Gantzer

Bob Gantzer

Head of Laboratory Automation, Beam Therapeutics
Bob currently serves as a Director at Beam Therapeutics where he leads the automation, robotics, and next generation sequencing (NGS) teams supporting cutting edge base editing research.  At Beam Therapeutics, Bob has led the implementation of industry leading lab automation, designed... Read More →


Tuesday June 22, 2021 11:00am - 11:25am EDT
Virtual

Attendees (8)